Akero Therapeutics Overview

Akero Therapeutics Operating Income

Operating Income for AKRO.

Quarterly Operating Income

$-90236000.00

↑ 10.44% YoY

As of Sep 30, 2025

Annual Operating Income (TTM)

$-330016000.00

↑ 22.56% YoY

Trailing 12 months ending Sep 30, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin